FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Istvan Szelenyi

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Anatomy

Eosinophils

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Istvan Szelenyi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Istvan Szelenyi
Flupirtine, a re-discovered drug, revisited.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2013;62(3):251-8.
2012: Istvan Szelenyi
Soft drugs for future treatment of chronic obstructive pulmonary disease (COPD).
Die Pharmazie 2012;67(5):371-3.
2006: Annette Amon; Andreas Pahl; Istvan Szelenyi
Is asthma research in dead end?
Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie 2006;57 Suppl 2():45-7.
2006: Annette Amon; Andreas Pahl; Istvan Szelenyi
Are there any realistic chances to develop new drugs for asthma?
Drug news & perspectives 2006;19(4):189-200.
2006: Annette Amon; Andreas Pahl; Istvan Szelenyi
Can corticosteroids be beaten in future asthma therapy?
Die Pharmazie 2006;61(2):122-4.
2006: István Kurucz; Istvan Szelenyi
Current animal models of bronchial asthma.
Current pharmaceutical design 2006;12(25):3175-94.
2005: Wolfgang Baeumer; Istvan Szelenyi; Manfred Kietzmann
Cilomilast, an orally active phosphodiesterase 4 inhibitor for the treatment of COPD.
Expert review of clinical immunology 2005;1(1):27-36.
2005: Burkhard Hinz; Julia Chevts; Bertold Renner; Henrike Wuttke; Thomas Rau; Andreas Schmidt; Istvan Szelenyi; Kay Brune; Ulrike Werner
Bioavailability of diclofenac potassium at low doses.
British journal of clinical pharmacology 2005;59(1):80-4.
2004: Istvan Szelenyi; Robert Hermann; U Petzold; Andreas Pahl; G Hochhaus
Possibilities in improvement of glucocorticoid treatments in asthma with special reference to loteprednol etabonate.
Die Pharmazie 2004;59(5):409-11.
2004: Mariann K Tapfer; Laszlo Sebestyen; István Kurucz; Katalin Horvath; Istvan Szelenyi; Nicholas Bodor
New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox.
Pharmacology, biochemistry, and behavior 2004;77(3):423-9.
2002: Andreas Pahl; Istvan Szelenyi
Asthma therapy in the new millennium.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2002;51(6):273-82.
2002: Andreas Pahl; Meixia Zhang; Katalin Török; Hildegard Kuss; Ute Friedrich; Zoltán Magyar; Jozsef Szekely; Katalin Horvath; Kay Brune; Istvan Szelenyi
Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787.
The Journal of pharmacology and experimental therapeutics 2002;301(2):738-46.
2002: Istvan Szelenyi; Kay Brune
Herbal remedies for asthma treatment: between myth and reality.
Drugs of today (Barcelona, Spain : 1998) 2002;38(4):265-303.
2002: Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.
British journal of pharmacology 2002;135(8):1915-26.
2002: Istvan Szelenyi; Andreas Pahl
Drug therapy in asthma bronchiale in the new millennium.
Die Pharmazie 2002;57(2):83-6.
2002: Degenhard Marx; Mahmoud Tassabehji; Sabine Heer; Karl-Bernd Hüttenbrink; Istvan Szelenyi
Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoids.
Pulmonary pharmacology & therapeutics 2002;15(1):7-15.
2002: Sabine Küsters; Rufina Schuligoi; Karl-Bernd Hüttenbrink; Jutta Rudert; Angela Wachs; Istvan Szelenyi; Bernhard A Peskar
Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells.
Arzneimittel-Forschung 2002;52(2):97-102.
2000: Istvan Szelenyi
Animal models of bronchial asthma.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2000;49(12):639-54.
2000: R Schindler; N Hoefgen; Kristina Heinecke; H Poppe; Istvan Szelenyi
Indazole-3-oles and indazole-2-ones with anti-inflammatory activity.
Die Pharmazie 2000;55(11):857.
2000: Istvan Szelenyi; G Hochhaus; Sabine Heer; S Kusters; D Marx; H Poppe; J Engel
Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways.
Drugs of today (Barcelona, Spain : 1998) 2000;36(5):313-20.
1999: C Menciu; Muriel Duflos; F Fouchard; Guillaume Le Baut; P Emig; U Achterrath; Istvan Szelenyi; B Nickel; J Schmidt; B Kutscher; E Günther
New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.
Journal of medicinal chemistry 1999;42(4):638-48.
1998: Gordon Dent; H Poppe; J Egerland; Degenhard Marx; Istvan Szelenyi; Detlev Branscheid; Helgo Magnussen; Klaus F Rabe
Effects of a selective PDE4 inhibitor, D-22888, on human airways and eosinophils in vitro and late phase allergic pulmonary eosinophilia in guinea pigs.
Pulmonary pharmacology & therapeutics 1998;11(1):13-21.
1998: R Schindler; I Fleischhauer; Norbert Höfgen; W Sauer; Ute Egerland; H Poppe; Sabine Heer; Istvan Szelenyi; B Kutscher; J Engel
1,5-Disubstituted indazol-3-ols with anti-inflammatory activity.
Archiv der Pharmazie 1998;331(1):13-21.
1997: B Nickel; W Kolasiewicz; Istvan Szelenyi
Quantification of rigidity and tremor activity in rats by using a new device and its validation by different classes of drugs.
Arzneimittel-Forschung 1997;47(10):1081-6.